CompaniesByCap
IBRX
ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare

ImmunityBio, Inc. Cash Flow 2013–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-304.9M-391.2M-366.8M-337.5M-274.4M-171.7M-152.1M-63.4M-48.8M-38.6M
Depreciation & Amort.15.5M17.6M18.5M18.3M14.2M12.7M14.0M9.6M5.6M3.6M
Investing Activities
Capital Expenditure3.8M6.9M30.6M78.2M33.6M1.7M4.3M13.1M34.8M6.6M
Free Cash Flow-308.8M-398.1M-397.3M-415.7M-308.0M-173.4M-156.4M-76.5M-83.6M-45.2M
Financing Activities
Dividends Paid
Stock Buybacks002.5M228,00015.2M15.8M

ImmunityBio, Inc. Cash Flow — FAQ

ImmunityBio, Inc. (IBRX) cash flow over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IBRX's cash flow history?

The chart and table above show ImmunityBio, Inc.'s cash flow by year and by quarter, including the growth rate.